Denise Kleiner-Hilfiker

Denise Kleiner-Hilfiker

Carl Neuberg Str
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 171 publications

High sensitivity for peripartum cardiomyopathy among large language models during differential diagnosis consideration.

High sensitivity for peripartum cardiomyopathy among large language models during differential diagnosis consideration.

Journal: Women's health (London, England)

Published: August 19, 2026

Serotonin 5-HT7 receptor signaling modulates inflammatory responses and survival after myocardial infarction.

Serotonin 5-HT7 receptor signaling modulates inflammatory responses and survival after myocardial infarction.

Journal: Journal of translational medicine

Published: April 15, 2026

Cardiogenic shock complicating peripartum cardiomyopathy benefits from combination therapy with levosimendan and bromocriptine.

Cardiogenic shock complicating peripartum cardiomyopathy benefits from combination therapy with levosimendan and bromocriptine.

Journal: European journal of heart failure

Published: September 22, 2025

Elevated Activin-A serum levels in patients with acute peripartum cardiomyopathy and during left ventricular recovery.

Elevated Activin-A serum levels in patients with acute peripartum cardiomyopathy and during left ventricular recovery.

Journal: ESC heart failure

Published: September 01, 2025

Peripartum cardiomyopathy.

Peripartum cardiomyopathy.

Journal: Lancet (London, England)

Published: January 30, 2025

Immune dysregulation as a key driver of peripartum cardiomyopathy - an exploratory advanced imaging and biomarker study.

Immune dysregulation as a key driver of peripartum cardiomyopathy - an exploratory advanced imaging and biomarker study.

Journal: European journal of heart failure

Published: January 02, 2025

Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model.

Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model.

Journal: Frontiers in molecular medicine

Published: August 28, 2024

Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registry.

Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registry.

Journal: European heart journal

Published: July 15, 2024

Cardiac dysfunction related to cardiac mRNA and protein traffic impairment due to reduced unconventional motor protein myosin-5b expression.

Cardiac dysfunction related to cardiac mRNA and protein traffic impairment due to reduced unconventional motor protein myosin-5b expression.

Journal: European heart journal

Published: June 17, 2024

Serotonin receptor 5-HT7 modulates inflammatory-associated functions of macrophages.

Serotonin receptor 5-HT7 modulates inflammatory-associated functions of macrophages.

Journal: Cellular and molecular life sciences : CMLS

Published: June 14, 2024

Pregnancies in women after peri-partum cardiomyopathy: the global European Society of Cardiology EuroObservational Research Programme Peri-Partum Cardiomyopathy Registry.

Pregnancies in women after peri-partum cardiomyopathy: the global European Society of Cardiology EuroObservational Research Programme Peri-Partum Cardiomyopathy Registry.

Journal: European heart journal

Published: May 30, 2024

Targeting the High-Density Lipoprotein Proteome for the Treatment of Post-Acute Sequelae of SARS-CoV-2.

Targeting the High-Density Lipoprotein Proteome for the Treatment of Post-Acute Sequelae of SARS-CoV-2.

Journal: International journal of molecular sciences

Published: February 13, 2024

Showing 1-12 of 171

Last Updated: 09/26/2026